EFFICACY OF ALFUZOSIN VERSUS CONTROL GROUP IN UPPER URETERIC STONE EXPULSION IN ADULT POPULATION OF LAHORE, PAKISTAN

IF 0.5 Q3 MEDICINE, GENERAL & INTERNAL Gomal Journal of Medical Sciences Pub Date : 2022-01-18 DOI:10.46903/gjms/19.04.904
Fawad Humayun, G. Mujtaba, M. Seerwan, Ghazi Khan, N. Javed, Muhammad Adnan
{"title":"EFFICACY OF ALFUZOSIN VERSUS CONTROL GROUP IN UPPER URETERIC STONE EXPULSION IN ADULT POPULATION OF LAHORE, PAKISTAN","authors":"Fawad Humayun, G. Mujtaba, M. Seerwan, Ghazi Khan, N. Javed, Muhammad Adnan","doi":"10.46903/gjms/19.04.904","DOIUrl":null,"url":null,"abstract":"Background: Urinary stone disease is one of the commonest urological diseases worldwide. The objective of this study was to compare the efficacy of alfuzosin versus control group in upper ureteric stone expulsion in adult population of district Lahore, Pakistan.Materials Methods: This trial was conducted in Department of Urology, Sheikh Zayed Hospital, Lahore, Pakistan form January 2017 to June 2017. All adult patients with upper ureteric stone size 5-10 mm were eligible. Those with multiple stones, having fever, severe pain, history of surgery in past two weeks and growth on urine culture or pyuria were excluded. Experimental and control groups each had 30 patients. Experimental group received Tab. alfuzosin 10 mg daily for four weeks and Tab. diclofenac sodium 50 mg SOS for acute pain. The control group received Tab. diclofenac sodium 50 mg SOS for acute pain. We followed all patients for four weeks for expulsion of ureteric stones by X-ray KUB or CT KUB. Sex, age and stone size were matching variables. Stone expulsion (yes, no) was research variable. We compared count of stone expulsion between two groups by using McNemar chi-square test at alpha 0.5 using GraphPad.Results: Out of 30 patients in experimental group, 23 (76.67%) were men and seven (23.33%) women and out of 30 in control group, 20 (66.67%) were men and 10 (33.33%) women, almost similar in both groups. Mean age in experimental group was 39.45±10.33 years and in control group it was 37.38±8.28 years, almost similar in both groups. Mean stone size was 7.45±1.47 (5-10) mm in the experimental and 7.28±1.68 (5-10) mm in control group, being comparable in both the groups. In experimental group, stone expulsion was achieved in 23 (76.67%) cases and not in seven (23.33%) cases and in control group, it was achieved in 16 (53.33%) cases and not in 14 (46.67%) cases. There was statistically no significant difference in efficacy of alfuzosin versus control group (p=.1213).Conclusion: Our study showed no difference in efficacy of alfuzosin versus control group for upper ureteric stone expulsion in adult population of district Lahore, Pakistan.","PeriodicalId":44174,"journal":{"name":"Gomal Journal of Medical Sciences","volume":" ","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2022-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gomal Journal of Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46903/gjms/19.04.904","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Urinary stone disease is one of the commonest urological diseases worldwide. The objective of this study was to compare the efficacy of alfuzosin versus control group in upper ureteric stone expulsion in adult population of district Lahore, Pakistan.Materials Methods: This trial was conducted in Department of Urology, Sheikh Zayed Hospital, Lahore, Pakistan form January 2017 to June 2017. All adult patients with upper ureteric stone size 5-10 mm were eligible. Those with multiple stones, having fever, severe pain, history of surgery in past two weeks and growth on urine culture or pyuria were excluded. Experimental and control groups each had 30 patients. Experimental group received Tab. alfuzosin 10 mg daily for four weeks and Tab. diclofenac sodium 50 mg SOS for acute pain. The control group received Tab. diclofenac sodium 50 mg SOS for acute pain. We followed all patients for four weeks for expulsion of ureteric stones by X-ray KUB or CT KUB. Sex, age and stone size were matching variables. Stone expulsion (yes, no) was research variable. We compared count of stone expulsion between two groups by using McNemar chi-square test at alpha 0.5 using GraphPad.Results: Out of 30 patients in experimental group, 23 (76.67%) were men and seven (23.33%) women and out of 30 in control group, 20 (66.67%) were men and 10 (33.33%) women, almost similar in both groups. Mean age in experimental group was 39.45±10.33 years and in control group it was 37.38±8.28 years, almost similar in both groups. Mean stone size was 7.45±1.47 (5-10) mm in the experimental and 7.28±1.68 (5-10) mm in control group, being comparable in both the groups. In experimental group, stone expulsion was achieved in 23 (76.67%) cases and not in seven (23.33%) cases and in control group, it was achieved in 16 (53.33%) cases and not in 14 (46.67%) cases. There was statistically no significant difference in efficacy of alfuzosin versus control group (p=.1213).Conclusion: Our study showed no difference in efficacy of alfuzosin versus control group for upper ureteric stone expulsion in adult population of district Lahore, Pakistan.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
阿复唑星与对照组在巴基斯坦拉合尔成人输尿管上段结石排出中的疗效
背景:尿路结石是世界上最常见的泌尿系统疾病之一。本研究的目的是比较阿福唑嗪与对照组在巴基斯坦拉合尔地区成年人群中上输尿管结石排出的疗效。材料方法:本试验于2017年1月至2017年6月在巴基斯坦拉合尔谢赫扎耶德医院泌尿科进行。所有上输尿管结石大小为5-10mm的成年患者均符合条件。排除那些有多发结石、发烧、剧烈疼痛、过去两周有手术史以及尿液培养生长或排尿困难的患者。实验组和对照组各有30名患者。实验组接受表阿呋唑嗪10mg,持续四周,表双氯芬酸钠50mg SOS治疗急性疼痛。对照组接受双氯芬酸钠50mg SOS治疗急性疼痛。我们对所有患者进行了为期四周的随访,通过X光KUB或CT KUB排出输尿管结石。性别、年龄和结石大小是匹配的变量。石头驱逐(是,否)是研究变量。结果:实验组30例患者中,23例(76.67%)为男性,7例(23.33%)为女性;对照组30例,20例(66.67%)为女性,10例(33.33%)为男性。实验组的平均年龄为39.45±10.33岁,对照组为37.38±8.28岁,两组几乎相似。实验组和对照组的平均结石大小分别为7.45±1.47(5-10)mm和7.28±1.68(5-10)毫米,两组具有可比性。实验组有23例(76.67%)结石排出,7例(23.33%)未排出,对照组有16例(53.33%)未排出14例(46.67%)。与对照组相比,阿福唑嗪的疗效在统计学上没有显著差异(p=.1213)。结论:我们的研究表明,在巴基斯坦拉合尔地区的成年人群中,阿福佐辛与对照组对上输尿管结石排出的疗效没有差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Gomal Journal of Medical Sciences
Gomal Journal of Medical Sciences MEDICINE, GENERAL & INTERNAL-
CiteScore
0.60
自引率
80.00%
发文量
37
审稿时长
40 weeks
期刊最新文献
PREVALENCE AND DETERMINANTS OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY IN PERINATAL ASPHYXIA POPULATION OF DISTRICT MARDAN, PAKISTAN EPITHELIOID SARCOMA OF WRIST IN 52 YEARS OLD FEMALE IN CHENNAI, INDIA PREVALENCE OF PHENOTYPIC CARBAPENEM-RESISTANT ENTEROBACTERALES ISOLATES AND THEIR DISTRIBUTION BY SEX, AGE GROUPS, STATE AND SPECIES IN SOUTH-EAST NIGERIA PREVALENCE OF RIFAMPICIN RESISTANCE AND PROBES IDENTIFICATION OF 81BP RRDR RPO-B GENE IN PULMONARY TUBERCULOSIS PATIENTS OF DISTRICT BANNU, PAKISTAN METHOTREXATE TOXICITY AS MYELOSUPPRESSION IN 66-YEAR-OLD FEMALE WITH RHEUMATOID ARTHRITIS IN CHENNAI, TAMIL NADU, INDIA
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1